Semax and Selank research, sorted
Semax and Selank are two short peptides people often ask about. In July 2026 an FDA advisory committee voted to recommend Semax for compounding. Selank was not on that committee's agenda.
- Evidence grade or review status for every compound
- Sources listed on every page
- US and sport status, dated
Compounds studied in this area
Grades describe the published evidence, not a promise of any effect.
Semax
Not approved by the FDA. An FDA advisory committee voted to recommend it for compounding in July 2026.
Read the Semax guideSelank
Formerly on FDA's Category 2 list; the nomination was withdrawn. Not on the July 2026 FDA advisory committee agenda or in the October 2026 HHS policy.
Read the Selank guideWhat has been studied
What the research does not show
Saying what we don't know is part of the evidence.
What Semax or Selank do in people. This page makes no statement about effects; the Semax and Selank guides set out the human studies, their design and their limits.
Where it stands legally
As of November 2026. See the full tracker and the changelog.
| Compound | FDA approval | 503A compounding (2026) | WADA (2026 List) |
|---|---|---|---|
| Semax | Not approved | FDA advisory committee voted for listing (Jul); HHS enforcement-discretion policy (Oct); no rule yet | Check with your anti-doping body |
| Selank | Not approved | Formerly FDA Category 2; nomination withdrawn (FDA list, current 22 Apr 2026); not on the July 2026 committee agenda or in the October HHS policy | Check with your anti-doping body |
Worth knowing
Research use only
None of the compounds on this page is an FDA-approved medicine. Nothing on this page is medical advice or describes use in people.
What research use only meansNo doses, ever
We publish no doses, protocols, or cycles for people, on any page.
Why we publish no dosesHow we grade evidence
Grades follow study design: cell and animal studies (preclinical), small human studies, then controlled human trials, with approval tracked separately. A grade is not a promise of any effect.
Evidence gradesQuestions people ask
Is Semax approved in the US?
No. The FDA has not approved it.
Are Semax and Selank allowed in sport?
Check with your anti-doping body. Our sport page explains how WADA's S0 class covers non-approved substances.
Sources
- U.S. Food and Drug Administration. Pharmacy Compounding Advisory Committee meeting page, 23–24 July 2026: agenda, voting questions and FDA briefing (no minutes posted as of 17 November 2026). www.fda.gov/advisory-committees/advisory-committee-calendar/july-23-24-2026-meeting-pharmacy-compounding-advisory-committee-07232026
- U.S. Department of Health and Human Services. Enforcement discretion policy regarding 503A compounding using certain peptide bulk drug substances, 28 Oct 2026. www.hhs.gov/sites/default/files/hhs-503a-peptide-enforcement-discretion-policy.pdf
- World Anti-Doping Agency. Prohibited List 2026 (in force 1 January 2026) and 2027 (in force 1 January 2027). www.wada-ama.org/en/prohibited-list
- U.S. Department of Health and Human Services. Enforcement discretion policy, Appendix B: peptide identities and justifications, October 2026 (records the July 2026 committee outcome for each of the six peptides). www.hhs.gov/sites/default/files/hhs-503a-peptide-enforcement-discretion-policy-appendix-b.pdf
- U.S. Food and Drug Administration. Certain bulk drug substances for use in compounding that may present significant safety risks. Content current as of 22 April 2026. www.fda.gov/drugs/human-drug-compounding/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks
Start with the evidence
Every page sourced and dated, including what the research does not show.
Open the research library